✦ LIBER ✦
552 POSTER Targeting MET with XL184 to reverse EGFR tyrosine kinase inhibitor (TKI) resistance in NSCLC: impact of preclinical studies on clinical trial design
✍ Scribed by P.A. Janne; M. Wax; J. Leach; J. Engelman
- Book ID
- 119599708
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 60 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.